Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2024-06-05 Transaction in Own Shar…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of 140,000 ordinary shares by the company as part of its 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming the information is provided by RNS (the news service of the London Stock Exchange) confirms it is a formal regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-06-05 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' where the company purchased 750,000 ordinary shares as part of its 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming the information is provided by RNS (the news service of the London Stock Exchange) confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-06-04 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the 'RNS Number : 9168Q' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content announces the 'Total Voting Rights' as of a specific date (3 June 2024, based on 31 May 2024 figures) and references DTR 5.6.1 (Disclosure and Transparency Rules). This type of mandatory regulatory disclosure regarding the total number of shares and voting rights, distributed via RNS, fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Total Voting Rights' announcements, and it is not a declaration of voting results (DVA) but a calculation denominator.
2024-06-03 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' detailing the purchase of 140,000 Ordinary Shares as part of a 'share buyback programme'. This directly corresponds to the definition of a company buying back or selling its own shares. The filing uses the RNS format, but the specific content maps precisely to the 'Transaction in Own Shares' category (POS).
2024-06-03 English
Autolus presents FELIX data at ASCO
Regulatory Filings Classification · 1% confidence The document is an announcement from Syncona Limited regarding data presented by its portfolio company, Autolus Therapeutics Plc, at the ASCO Annual Meeting. The text contains an RNS Number (6981Q), a date (31 May 2024), and details clinical trial results (FELIX study of obe-cel). It also mentions that a conference call and webcast will be hosted to summarize the data and refers to the company's website for copies of the press release. This structure—a brief announcement detailing recent news, often referencing an attached or linked full report/presentation, and including contact information—is characteristic of a general regulatory announcement or press release that doesn't fit a specific financial reporting category like 10-K or IR. Since it is a formal announcement disseminated via RNS, and it is not a specific financial report (like ER, IR, or 10-K) nor an announcement *about* a report publication (RPA), the most appropriate fallback category is Regulatory Filings (RNS). The document length is substantial (over 16k chars), but its primary function is disseminating time-sensitive, non-financial-statement news.
2024-05-31 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of 140,000 ordinary shares by the company as part of a share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming the information is provided by RNS suggests it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-05-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.